Answer
Medabon (mifepristone and misoprostol) is indicated for medical termination of a developing intra-uterine pregnancy up to 63 days of amenorrhoea.
Sources for this answer
- Medabon - Combipack of Mifepristone 200 mg tablet and Misoprostol 4 x 0.2 mg vaginal tabletsRanbaxy (UK) Limited a Sun Pharmaceutical Company · emc · SmPC §4.1 Therapeutic Indications · Version 5Document updated
Sources checked